Literature DB >> 32241791

To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic.

Francesca Romana Spinelli1, Fulvia Ceccarelli2, Manuela Di Franco2, Fabrizio Conti2.   

Abstract

Entities:  

Keywords:  communicable diseases, imported; hydroxychloroquine; immune system diseases; social work

Mesh：

Substances：

Year:  2020        PMID： 32241791     DOI： 10.1136/annrheumdis-2020-217367

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  18 in total

1.  Being a rheumatologist and a patient with a rheumatic disease today: A perspective at the time of COVID-19.

Authors:  Carlo Perricone; Roberto Gerli
Journal:  Eur J Rheumatol       Date:  2020-04-10

Review 2.  Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials.

Authors:  Virgilio Galvis; Francesca Romana Spinelli; Alejandro Tello; Claudia L Sossa; Juan D Higuera; Edgar D Gómez; Sergio E Serrano; Paul A Camacho; Federico G Velez
Journal:  Arch Bronconeumol (Engl Ed)       Date:  2020-05-31       Impact factor: 4.872

Review 3.  Safety perspectives on presently considered drugs for the treatment of COVID-19.

Authors:  Sophie L Penman; Robyn T Kiy; Rebecca L Jensen; Christopher Beoku-Betts; Ana Alfirevic; David Back; Saye H Khoo; Andrew Owen; Munir Pirmohamed; B Kevin Park; Xiaoli Meng; Christopher E Goldring; Amy E Chadwick
Journal:  Br J Pharmacol       Date:  2020-08-13       Impact factor: 8.739

Review 4.  COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?

Authors:  Serena Colafrancesco; Cristiano Alessandri; Fabrizio Conti; Roberta Priori
Journal:  Autoimmun Rev       Date:  2020-05-05       Impact factor: 9.754

5.  Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020.

Authors:  Christophe Richez; René-Marc Flipo; Francis Berenbaum; Alain Cantagrel; Pascal Claudepierre; Françoise Debiais; Philippe Dieudé; Philippe Goupille; Christian Roux; Thierry Schaeverbeke; Daniel Wendling; Thao Pham; Thierry Thomas
Journal:  Joint Bone Spine       Date:  2020-05-27       Impact factor: 4.929

Review 6.  Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients.

Authors:  Serena Colafrancesco; Rossana Scrivo; Cristiana Barbati; Fabrizio Conti; Roberta Priori
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

Review 7.  COVID-19 diagnosis and management: a comprehensive review.

Authors:  Giuseppe Pascarella; Alessandro Strumia; Chiara Piliego; Federica Bruno; Romualdo Del Buono; Fabio Costa; Simone Scarlata; Felice Eugenio Agrò
Journal:  J Intern Med       Date:  2020-05-13       Impact factor: 13.068

Review 8.  COVID-19 revisiting inflammatory pathways of arthritis.

Authors:  Georg Schett; Bernhard Manger; David Simon; Roberto Caporali
Journal:  Nat Rev Rheumatol       Date:  2020-06-19       Impact factor: 20.543

9.  The correlation between SARS-CoV-2 infection and rheumatic disease.

Authors:  Zhao-Wei Gao; Xi Wang; Fang Lin; Ke Dong
Journal:  Autoimmun Rev       Date:  2020-05-01       Impact factor: 9.754

10.  Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy.

Authors:  Carlo Salvarani; Pamela Mancuso; Federica Gradellini; Nilla Viani; Paolo Pandolfi; Massimo Reta; Giuliano Carrozzi; Gilda Sandri; Gianluigi Bajocchi; Elena Galli; Francesco Muratore; Luigi Boiardi; Nicolò Pipitone; Giulia Cassone; Stefania Croci; Anna Maria Marata; Massimo Costantini; Paolo Giorgi Rossi
Journal:  Arthritis Rheumatol       Date:  2020-11-27       Impact factor: 15.483
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.